Skip to main content

Table 2 Clinical characteristics of ICU survivors and interviewees

From: Long-term health-related quality of life and burden of disease after intensive care: development of a patient-reported outcome measure

  ICU survivors
(n = 395)
Interviewees
(n = 32)
Primary diagnosis, n (%)   
Infection/sepsis 110 (27.8) 6 (18.8)
Trauma 53 (13.4) 4 (12.5)
Respiratory failure 43 (10.9) 3 (9.4)
Major bleeding1 38 (9.6) 0 (0.0)
Cardiac arrest 24 (6.1) 4 (12.5)
GI diseases2 17 (4.3) 3 (9.4)
Liver failure 16 (4.1) 1 (3.1)
Transplantation 16 (4.1) 3 (9.4)
Postoperative 16 (4.1) 1 (3.1)
Renal failure 12 (3.0) 3 (9.4)
Pulmonary diseases3 10 (2.5) 0 (0.0)
Cardiac failure and/or myocardial infarction 10 (2.5) 2 (6.3)
Vascular disorders4 10 (2.5) 0 (0.0)
Metabolic disorders 8 (2.0) 0 (0.0)
Other 7 (1.8) 2 (6.3)
Oncological or haematological disorders 5 (1.3) 0 (0.0)
SAPS3 score   
Median (range) 59 (16–100) 57.5 (24–81)
ICU, length of stay   
Days, median (range) 5.5 (3.0–78.6) 4.9 (1.7–76.1)
Mechanical ventilation   
Patients, n (%) 310 (78.5) 23 (69.7)
Days, median (range) 5.0 (1.0–74.0) 5 (1.0–62.0)
Continuous renal replacement therapy   
Patients, n (%) 88 (22.3) 11 (33.0)
Days, median (range) 6.0 (1.0–42.0) 8.0 (3.0–53.0)
  1. 1including aortic rupture and GI bleeding; 2including pancreatitis and peritonitis; 3including COPD and pneumonitis; 4 including emboli and thrombi